Coordinatore | BEN-GURION UNIVERSITY OF THE NEGEV
Organization address
address: Office of the President - Main Campus contact info |
Nazionalità Coordinatore | Israel [IL] |
Totale costo | 7˙184˙970 € |
EC contributo | 5˙596˙607 € |
Programma | FP7-KBBE
Specific Programme "Cooperation": Food, Agriculture and Biotechnology |
Code Call | FP7-KBBE-2010-4 |
Funding Scheme | CP-IP |
Anno di inizio | 2011 |
Periodo (anno-mese-giorno) | 2011-01-01 - 2013-12-31 |
# | ||||
---|---|---|---|---|
1 |
BEN-GURION UNIVERSITY OF THE NEGEV
Organization address
address: Office of the President - Main Campus contact info |
IL (BEER SHEVA) | coordinator | 699˙719.25 |
2 |
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Organization address
address: Rue Michel -Ange 3 contact info |
FR (PARIS) | participant | 593˙520.00 |
3 |
UNIVERSITY COLLEGE LONDON
Organization address
address: GOWER STREET contact info |
UK (LONDON) | participant | 527˙416.00 |
4 |
ROTHAMSTED RESEARCH LIMITED
Organization address
address: West Common contact info |
UK (HARPENDEN) | participant | 520˙181.75 |
5 |
UNIVERSITE LE MANS
Organization address
address: AVENUE OLIVIER MESSIAEN contact info |
FR (Le Mans) | participant | 487˙730.00 |
6 |
UNIVERSITA DEGLI STUDI DI FIRENZE
Organization address
address: Piazza San Marco 4 contact info |
IT (Florence) | participant | 487˙682.40 |
7 |
GEORG-AUGUST-UNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS
Organization address
address: WILHELMSPLATZ 1 contact info |
DE (GOTTINGEN) | participant | 466˙200.00 |
8 |
ROSETTA GREEN LTD
Organization address
address: PLAUT ST 10 contact info |
IL (REHOVOT) | participant | 412˙898.40 |
9 |
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT AM MAIN
Organization address
address: GRUNEBURGPLATZ 1 contact info |
DE (FRANKFURT AM MAIN) | participant | 402˙879.60 |
10 |
A4F ALGAFUEL SA
Organization address
address: BELAMANDIL contact info |
PT (OLHAO) | participant | 400˙550.00 |
11 |
ALGATECHNOLOGIES (1998) LTD
Organization address
address: Kibbutz Ketura contact info |
IL (D.N. EILOT) | participant | 392˙560.00 |
12 |
Nimrod Shaham & Amos Zamir Certified Public Accountants
Organization address
address: Shapira 16 contact info |
IL (Ramat Gan) | participant | 120˙000.00 |
13 |
A B SEEDS LTD
Organization address
address: GAD FEINSTEIN 13 contact info |
IL (REHOVOT) | participant | 85˙269.60 |
14 |
ROSETTA GENOMICS LTD
Organization address
address: Plaut Street 10 contact info |
IL (Rehovot) | participant | 0.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Microalgae are a highly promising resource for the sustainable production of a wide variety of biomaterials for a wide range of applications. Microalgae can transform solar energy at high efficiency directly into valuable biological products using marginal water resources, waste nutrients and exhaust CO2 without the needs for high value cropland. A wide variety of eukaryotic microalgae of high evolutionary diversity produce naturally valuable products like polyunsaturated fatty acids, carotenoids, medically active carbohydrates etc. Nevertheless only a few commercially viable algal products have entered the market. Algal cultivation and induction of high value product accumulation is a complex problem, algae grow in diluted solutions and require large areas and water volumes, causing high cultivation and harvesting costs and posing contamination problems and variable productivities due to climate variability. Genetic modifications to make microalgae better suit industrial applications are possible over a wide range of target mechanisms: stress tolerance, product accumulation pathways, cellular chlorophyll contents, novel metabolic pathways, resistance to pathogens and competition, etc. Due to the wide variability of algal strains under consideration, available techniques for genetic manipulations have to be adapted or developed for all algal strains of interest. Our consortium will adapt genetic engineering techniques to various algal strains of economic interest focusing on carotenoid and PUFA production and the overexpression of peptides of commercial value. In parallel we will develop cultivation technologies, harvesting and extraction methods for lipids, carotenoids and proteins using existing model algae strains that will then be adapted to suitable improved strains. Furthermore products will be tested for energy, pharmaceutical, nutritional or medical applications for economic evaluation of the production processes and their economic exploitation.'
Microalgae produce a variety of useful products that can be used by the pharmaceutical and cosmetics industries, and are also a potential source of biofuel. An EU-funded initiative sought to improve algae strains and cultivation techniques in order to reduce algal biomass production costs.